We found a significant upregulation of MICA and PVR/CD155 mRNA and cell surface expression by lenalidomide and pomalidomide; accordingly, NK-cell degranulation was enhanced upon interaction with IMiDs-treated tumor cells. This evidence concerns the gene PVR and neoplasm.